# Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Chronic Low Back Pain

> **NCT05086289** · PHASE2 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 159 (actual)

## Conditions studied

- Chronic Low-back Pain

## Interventions

- **DRUG:** LY3526318
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05086289
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-25
- **Primary completion:** 2022-06-17
- **Final completion:** 2022-06-17
- **Target enrollment:** 159 (ACTUAL)
- **Last updated:** 2023-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05086289

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05086289, "Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Chronic Low Back Pain". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT05086289. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*